Daily News Podcast

Lorcaserin shows cardiovascular safety

Publish date: August 27, 2018

 

Lorcaserin is the first weight-loss drug proven to have cardiovascular safety. Also today, live attenuated flu vaccine gets the nod for upcoming flu season, PCSK9 inhibition helps patients with metabolic syndrome, and breastfeeding may reduce the risk of stroke decades later. Subscribe to the MDedge Daily News wherever you get your podcasts.

Amazon Alexa
Apple Podcasts
Spotify

Recommended Reading

French warn of upsurge in pneumococcal meningitis
MDedge Neurology
Variation doesn’t mean quality when it comes to diet
MDedge Neurology
Medicare Advantage pushback
MDedge Neurology
Cardiovascular risk management supported for type 2 diabetes
MDedge Neurology
An epidemic of non-alcoholic fatty liver disease
MDedge Neurology
AAN and others update practice guidelines for prolonged disorders of consciousness
MDedge Neurology
Sleepio app tied to reducing insomnia, depression
MDedge Neurology
5 digital HIPAA myths
MDedge Neurology
Screen for cervical cancer based on age, risk
MDedge Neurology
Is it time for PCPs to take over chronic HCV?
MDedge Neurology